I didn't think the results from the PIII trial were any better then the drugs already out there already. Does
anyone have a different take on this drug? Is approval in the bag?
IMO, they wanted this deal as bad as OPK. They got a peak inside and heard the vision for the future straight from Dr Frost and were all in. OPK got a great deal and the lower share price made it that much better. i can't believe I've been able to buy OPK under $12.50 and couldn't be happier with how this played out. Let's see if Dr Frost was in the market today buying hand over fist.
I think that the Good Dr needs to get the share price higher by the BRLI shareholder vote
to ensure he gets this company. Has he made an open market purchase, last one I see
is July 8th? Long periods of no buying means he usually cutting a deal.
Most vocal person on the panel against it was from GLAXO. You just can't make this sh-t up.
A government of the people and for the people is dead and it has been throughly corrupted by corporate money at every level.
Amarin really got screwed by the FDA. The panel the FDA assembled to review the drug and issue a
recommendation had THREE competitors on it and the FDA played right along. The supreme's could
not reverse the damage but now at least Amarin can now show and talk about the Anchor study results to
Make no mistake about it, this ruling is huge for Rayaldee.
Longs who have been here a while know whats' coming when the good Dr goes weeks without buying shares.
It usually means a deal ls coming and the deal in this case, IMO, is for ROW marketing rights for Rayaldee.
As I've speculated in the past, I believe ROW for Rayaldee is in play and PFE is my pony. OPK has done all the heavy lifting so the upfront $'s Frost could get might be too much for him to pass up. We'll even let PFE pay for the upcoming trials in cancer, RA, MS, Chrohn's ect, ect. ect. Frost could of course go it alone but......
Rayaldee could become standard care for several inflammation diseases, MS comes to mind right off the bat, Crohn's, cardio vascular ect, etc. Trials will of course need to be conducted. Off label usage? big time
"Through diagnostics we can enable physicians to a make a more targeted and precise approach in their
treatment strategies and thus improve patient outcomes & LOWER OVERALL HEALTHCARE COSTS".
The good Dr commenting on the 4K test not the BRLI buyout but you get the gist. Either you believe the future is personalized medicine, as the Dr does, or you don't.
and everyone is entitled to have one. Take the Barron's article for what it is, one persons opinion. Face it, some people do not share the good Dr's vision of health care now and in the future and that is jim dandy fine by me. Dr Frost called the generic explosion and made BILLIONS. Now the good Dr is betting on personalized health care and there are plenty of fools that will bet against him and lose.
Think about the possibilities. How much market share will we be able to capture once Claros is online? Dr's can do some testing, right in the office, think Vitamin D, etc, etc, with the outside tests being done at our labs. The revenue generator Claros will be for the Dr's office will assure its quick adoption. You could, in theory, give the Claros units away knowing you'll get it back with the assay & cassette sales. IMO, its a huge incentive for the Dr to give you their outside testing business. Of course, while they are in the office giving them the unit, it would be an ideal time to discuss the vitamin D test and of course Rayaldee.
Again, Claros has not been discussed by OPK or mentioned by BRLI management, its been all about the 4K.
Please, OPK has a plan for CLAROS and BRLI is going to execute it and we THE shareholders are going to reap the benefits. Lab Corp and Quest are going to be bleeding business profusely from the wounds this merger is going to inflict on them.
CLAROS, give it away I say.
Well all you need to know about Teva management is that they walked away from a Prolor deal before OPK got involved. Word had it Frost was pushing hard for Teva to make the deal and the CEO was dead set against it.
On 4/24/2013 OPK bought Prolor for $480 mil. Stock price high the day before was $7.20, stock sold off over the next few days to a low of $6.27 (approx a 12.5% selloff). The stock bounced around for the next few months, all the while Dr Frost was buying hand over fist. Fast forward to 12/15/2014 when OPK announced the deal, for the Prolor growth hormone drug with PFE for $295 upfront that sent the stock soaring.
Here we are today 6/10/2015, OPK just bought BRLI and the stock has sold off around 16%. History tells us that 18 months from now we will look back on this deal the same way we look back at the Prolor deal. Did someone say BUYING OPPORTUNITY?
The management team @ OPK is methodically building a full service heath care company of the future in the vision of Dr Frost. Folks are plain stupid betting against this guy.
Now I understand the silence surrounding Claros and this deal might be Dr Frost's most brilliant stroke yet. Claros not doubt put BRLI management on notice that times were a changing and either get on board or get
run over. I had speculated that OPK would partner up Claros and here Dr Frost goes and buys a sales force and state of the art company that perfectly compliments his long term vision. Kidos to BRLI management for having some vision here, IMO they took less money upfront to get this deal done. This deal is a game
changer, Quest and Lab Corp are now officially on notice, its not business as usual anymore.
I think wall st. will now finally sit up and take notice of what we have here, our company is still way
under owned on wall st. BRLI did $800 million and if you add in future Rayaldee revenue, 4K, TSRO
royalties, ect., etc., billions in revenues is right around the corner. BTW, did you notice who are the two top institutional holders of BRLI? They should be very familiar to OPK longs and assure approval of this deal.
I guess we need to speculate on what the next deal will be. Can you imagine what Dr Frost could do with
ROW marketing rights cash for Rayaldee? He has been a wheeling and dealing machine since the PFE
deal and that brought in $295 mil upfront, Rayaldee rights will cost 2 or 3 times that.
I assume Dr Frost was buying Friday, filing has not been posted on NASDAQ yet.
The importance of this buyout will become even more apparent down the road a piece. The deal has obviously already paid for itself but the real exciting stuff is still to come. Prolor not only had a pipeline, they have a biologics platform delivery system. Its one thing to find biologics that do what you want them to do but its an entirely different animal delivering it to the target in the human body intact (see the COCP merger).
Anyone think for a moment that DR Frost is done dealing? I didn't think so.
Long term this is a great day for OPK shareholders. This is another very smart and timely buy by the OPK team. History tells us that Dr Frost will leverage this deal into big gains for shareholders, its what he does. I've
been doing some research into the bio similar stocks and Bio Ref is the anti bio similar company in that they will and have discovered the next generation of biologics. The good Dr sees personalized medicine as the future and he is positioning OPK in the sweet spot. Of course it doesn't hurt to have a seasoned sales force selling the 4K. At $1.5 billion, OPK paid roughly 30X earnings and less then 2x revenues (Bio Ref grew revenues 15% last Q)